Shilpa Medicare Limited - Due diligence report
A 360° intelligence report on Vbshilpa: trust score, financial health, credit view, compliance, directors, growth and distress signals - gen…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Vbshilpa — 360° Intelligence Report
Generated from MCA filings & public recordsVbshilpa is assessed as Low Risk with a Trust Score of 78/100. Vbshilpa is an active public limited indian non-government company incorporated in 1987, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 18 Aug 2026 from the latest processed filings. Shilpa Medicare Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Liabilities ≈ 38% EBITDA - stretched.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A).
Charges position: 7 open (122.80 cr) · 44 satisfied (1,670.23 cr).
| Lender | Charges | Amount |
|---|---|---|
| Others | 6 | 48.0 cr |
| Axis Bank Limited | 6 | 48.0 cr |
| Standard Chartered Bank | 6 | 48.0 cr |
| The Hongkong And Shanghai Banking Corporation Limited | 3 | 48.0 cr |
| Hdfc Bank Limited | 3 | 48.0 cr |
| Icici Bank Limited | 2 | 48.0 cr |
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE, SEBI.
- Litigation present in 4 court forum(s).
- Delayed payments to MSME suppliers disclosed (69 disclosure(s)).
- 6 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ANITA BANDYOPADHYAY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ALPESH MAHESHKUMAR DALAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VISHNUKANTH CHATURBHUJ BHUTADA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HETAL MADHUKANT GANDHI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| REETU SHARMA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KALAKOTA REDDY SHARATH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| OM PRAKASH INANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Ritu Tiwary | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Ashraf Loutfy Abdelhamid Allam | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 9 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
Ownership & Group Intelligence
As per FY 2025 annual returnPromoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Pilnova Pharma, Inc. | Subsidiary Company | 74.00% |
| Koanaa Healthcare Limited | Subsidiary Company | 74.00% |
| Shilpa Pharma Lifesciences Limited | Subsidiary Company | 74.00% |
| Ftf Pharma Private Limited | Subsidiary Company | 74.00% |
| Shilpa Biologicals Private Limited | Subsidiary Company | 74.00% |
| Shilpa Therapeutics Private Limited | Subsidiary Company | 74.00% |
| Shilpa Biocare Private Limited | Subsidiary Company | 74.00% |
| Sampra Corporate Holdings Private Limited | Subsidiary Company | 74.00% |
| Inm Technologies Private Limited | Subsidiary Company | 74.00% |
| Sravathi Advance Process Technologies Private Limited | Joint Ventures | 74.00% |
Key managerial personnel: ALPESH MAHESHKUMAR DALAL (CFO) · VISHNUKANTH CHATURBHUJ BHUTADA (Managing Director) · KALAKOTA REDDY SHARATH (Whole-time director)
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 70 · Distress 80Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 7 open charge(s) of 122.80 cr already registered.
- Compliance gaps should be priced into terms.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Merchem | U24299WB1994PLC240045 | Kolkata, West Bengal, India |
| Hindustan Organic Chemicals | L99999KL1960GOI082753 | Kunnathunad, Kerala, India |
| Anlon Healthcare Limited | L24230GJ2013PLC077543 | Rajkot, Gujarat, India |
| Tanfac | L24117TN1972PLC006271 | Cuddalore 607005, Tamil Nadu, India |
| Bajaj Health | L99999MH1993PLC072892 | Thane West, Maharashtra, India |
| Hindys Lab Private Limited | U24100TG2007PTC055636 | Chityal, Telangana, India |
| Dfe Pharma | U24299TN2019FTC129309 | Cuddalore, Tamil Nadu, India |
| Punjab Alkalies & Chemicals Lt | L24119CH1975PLC003607 | Chandigarh, Chandigarh, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Vbshilpa before audits and certifications: compliance score 42/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Vbshilpa: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Vbshilpa - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Vbshilpa pays its suppliers before you extend credit terms.
Litigation footprint (4 case(s) on record), regulatory flags, charge documents trail and director networks for Vbshilpa - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Vbshilpa an active company?
Vbshilpa has MCA status “Active” with a compliance score of 42/100 (Caution Indicated).
Is Vbshilpa financially healthy?
Vbshilpa has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Vbshilpa?
Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Vbshilpa?
Promoters hold a minority stake - exact percentages are in the full report. 9 active director(s) are on record.
Does Vbshilpa have loans or charges against its assets?
7 open charge(s) are registered against its assets, and 44 earlier charge(s) stand satisfied.
Is Vbshilpa up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 42/100 (Caution Indicated).
Is it risky to lend to Vbshilpa?
Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.